Klinika Oczna
twitter
en ENGLISH
eISSN: 2719-3209
ISSN: 0023-2157
Klinika Oczna / Acta Ophthalmologica Polonica
Bieżący numer Archiwum Filmy Artykuły w druku O czasopiśmie Suplementy Rada naukowa Recenzenci Bazy indeksacyjne Prenumerata Kontakt Zasady publikacji prac Opłaty publikacyjne Standardy etyczne i procedury
Panel Redakcyjny
Zgłaszanie i recenzowanie prac online
SCImago Journal & Country Rank
Poleć ten artykuł:
Udostępnij:
streszczenie artykułu:
Opis przypadku

Diagnosis and management of uveitis-glaucoma-hyphema syndrome

Maria Guszkowska
1
,
Monika Popowska
1
,
Monika Lazicka-Galecka
1, 2
,
Tomasz Galecki
2
,
Anna Kaminska
1, 2, 3
,
Jacek Pawel Szaflik
1, 2, 3

  1. SPKSO Ophthalmic University Hospital Warsaw, Poland
  2. Department of Ophthalmology Medical University of Warsaw, Poland
  3. Laser Eye Microsurgery Centre in Warsaw, Poland
KLINIKA OCZNA 2025, 127
Data publikacji online: 2025/09/05
Pełna treść artykułu Pobierz cytowanie
 
Metryki PlumX:


We present a diagnostically challenging case of uveitis-glaucoma-hyphema (UGH) plus syndrome, emphasizing the importance of imaging modalities, particularly ultrasound biomicroscopy, in identifying intraocular lens (IOL)-related mechanical complications.

A 42-year-old woman with a history of juvenile cataract surgery and posterior chamber IOL implantation presented with recurrent anterior uveitis, vitreous hemorrhage, and secondary glaucoma in the left eye. Despite multiple surgical interventions – including trabeculectomy, revision surgery, and pars plana vitrectomy – her symptoms persisted. Standard workup for infectious and autoimmune uveitis was negative.

Ultrasound biomicroscopy revealed iris-IOL chafing, confirming the diagnosis of UGH plus syndrome. The malpositioned IOL was surgically explanted. This led to complete resolution of inflammation, cessation of hemorrhage, and long-term intraocular pressure (IOP) stabilization without the need for further surgical intervention.

Uveitis-glaucoma-hyphema plus syndrome should be suspected in pseudophakic patients with recurrent anterior and vitreous hemorrhage unresponsive to conventional therapies. Early use of imaging and timely IOL explantation can prevent irreversible vision loss.
© 2025 Termedia Sp. z o.o.
Developed by Bentus.